Beyond Air, Inc. Loss Contingency Accrual
Beyond Air, Inc. (XAIR) had Loss Contingency Accrual of $7.60 million as of 2023-03-31, per its 10-K filed 2023-06-22.
Discontinued › Notes › Commitment and Contingencies › Loss Contingency › Loss Contingency Accrual, Disclosures
us-gaap:LossContingencyAccrualAtCarryingValue · last filed 2023-06-22
- 2023-03-31: Loss Contingency Accrual $7.60M.
- 2022-12-31: Loss Contingency Accrual $200.00K.
- 2021-09-30: Loss Contingency Accrual $2.40M.
| Period end | Loss Contingency Accrual |
|---|---|
| 2023-03-31 | $7.60M 10-K · filed 2023-06-22 |
| 2022-12-31 | $200.00K 10-Q · filed 2023-02-10 |
| 2021-09-30 | $2.40M 10-Q · filed 2023-02-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |